Rouge Pascal, Dassonville-Klimpt Alexandra, Cézard Christine, Boudesocque Stéphanie, Ourouda Roger, Amant Carole, Gaboriau François, Forfar Isabelle, Guillon Jean, Guillon Emmanuel, Vanquelef Enguerran, Cieplak Piotr, Dupradeau François-Yves, Dupont Laurent, Sonnet Pascal
Laboratoire des Glucides, CNRS FRE 3517, UFR de Pharmacie, Université de Picardie Jules Verne, 1, rue des Louvels, 80037 Amiens cedex 1 (France).
Institut de Chimie Moléculaire de Reims (ICMR), UMR CNRS 7312, UFR des Sciences Exactes et Naturelles, Université de Reims Champagne-Ardenne, Reims (France).
Chempluschem. 2012 Nov 1;77(11):1001-1016. doi: 10.1002/cplu.201200141.
Iron chelators, through their capacity to modulate the iron concentration in cells, are promising molecules for cancer chemotherapy. Chelators with high lipophilicity easily enter into cells and deplete the iron intracellular pool. Consequently, iron-dependent enzymes, such as ribonucleotide reductase, which is over-expressed in cancer cells, become nonfunctional. A series of calix[4]arene derivatives substituted at the lower rim by ICL670, a strong Fe chelator, have been synthesized. Physicochemical properties and antiproliferative, angiogenesis, and tumorigenesis effects of two calix[4]arenes mono- () or disubstituted () with ICL670 have been studied. These compounds form metal complexes in a ratio of one to two ligands per Fe atom as shown by combined analyses of the protometric titration curves and ESIMS spectra. The grafting of an ICL670 group on a calix[4]arene core does not significantly alter the acid-base properties, but improves the iron-chelating and lipophilicity properties. The best antiproliferative and anti-angiogenic results were obtained with calix[4]arene ligand , which possesses the highest corresponding properties. Analyses of molecular dynamics simulations performed on the two calix[4]arenes provide three-dimensional structures of the complexes and proved to be the most stable upon complexation.
铁螯合剂因其调节细胞内铁浓度的能力,是癌症化疗中很有前景的分子。具有高亲脂性的螯合剂容易进入细胞并耗尽细胞内铁池。因此,在癌细胞中过度表达的铁依赖性酶,如核糖核苷酸还原酶,会失去功能。已经合成了一系列在下缘被强铁螯合剂ICL670取代的杯[4]芳烃衍生物。研究了两种用ICL670单取代()或双取代()的杯[4]芳烃的物理化学性质以及抗增殖、血管生成和肿瘤发生作用。如通过质子滴定曲线和电喷雾离子质谱(ESIMS)光谱的联合分析所示,这些化合物形成每个铁原子与一到两个配体比例的金属配合物。在杯[4]芳烃核心上接上一个ICL670基团不会显著改变酸碱性质,但会改善铁螯合和亲脂性性质。用具有最高相应性质的杯[4]芳烃配体获得了最佳的抗增殖和抗血管生成结果。对两种杯[4]芳烃进行的分子动力学模拟分析提供了配合物的三维结构,并证明在络合时是最稳定的。